Yidu Tech, Inc. (HK:2158)
:2158
2158 Stock Chart & Stats
HK$5.58
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.58
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$4.65 - HK$7.24
Previous CloseN/A
Volume5.15M
Average Volume (3M)6.50M
Market Cap
HK$5.46B
Enterprise ValueHK$3.69B
Total Cash (Recent Filing)HK$2.26B
Total Debt (Recent Filing)HK$130.73M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,072,650,600
10 Day Avg. Volume6,345,530
30 Day Avg. Volume6,499,248
Financial Highlights & Ratios
PEG Ratio1.23
Price to Book (P/B)1.55
Price to Sales (P/S)8.53
P/FCF Ratio-17.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$11.00Price Target Upside97.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.05
Revenue Forecast (FY)HK$917.00M
Bulls Say, Bears Say
Bulls Say
Low Leverage And Strong Equity BaseA very low debt-to-equity ratio and an equity ratio around 83.6% provide durable financial flexibility. This conservatism reduces insolvency risk, supports continued R&D and product investment without urgent refinancing, and preserves optionality for strategic moves over months.
Improving Free Cash Flow GenerationNotable free cash flow growth and a positive free cash flow-to-net-income ratio signal improving cash conversion despite losses. Sustained FCF improvement could fund operations or targeted investments, lengthen runway, and reduce reliance on external capital over the coming quarters.
Healthcare AI Data Franchise And Customer MixThe company's core capability—structuring real-world clinical data and delivering analytics for hospitals and pharma—matches long-term structural demand in healthcare AI and real-world evidence. Broad application (clinical, operational, R&D) supports sustained addressable market and recurring service demand.
Bears Say
Declining Revenue GrowthReported revenue contraction (negative growth) is a material structural concern: persistent top-line decline limits scale economics, pressures margins and R&D leverage, and signals challenges in customer adoption or pricing that could impair recovery prospects across multiple quarters.
Negative Profitability And MarginsSustained negative net profit and EBIT margins reduce internal capital generation and depress returns on invested capital. Continued unprofitability forces dependence on external funding or dilution and constrains reinvestment capacity, affecting long-term competitiveness and shareholder returns.
Negative Operating Cash FlowPersistent negative operating cash flow indicates the core business is not yet cash-generative. This structural cash burn necessitates ongoing financing or asset sales, limits capacity for scaling commercial efforts, and raises execution risk over the medium term.
Yidu Tech, Inc. News
2158 FAQ
What was Yidu Tech, Inc.’s price range in the past 12 months?
Yidu Tech, Inc. lowest stock price was HK$4.65 and its highest was HK$7.24 in the past 12 months.
What is Yidu Tech, Inc.’s market cap?
Yidu Tech, Inc.’s market cap is HK$5.46B.
When is Yidu Tech, Inc.’s upcoming earnings report date?
Yidu Tech, Inc.’s upcoming earnings report date is Jul 01, 2026 which is in 85 days.
How were Yidu Tech, Inc.’s earnings last quarter?
Yidu Tech, Inc. released its earnings results on Nov 27, 2025. The company reported -HK$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.011.
Is Yidu Tech, Inc. overvalued?
According to Wall Street analysts Yidu Tech, Inc.’s price is currently Undervalued.
Does Yidu Tech, Inc. pay dividends?
Yidu Tech, Inc. does not currently pay dividends.
What is Yidu Tech, Inc.’s EPS estimate?
Yidu Tech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yidu Tech, Inc. have?
Yidu Tech, Inc. has 1,072,650,600 shares outstanding.
What happened to Yidu Tech, Inc.’s price movement after its last earnings report?
Yidu Tech, Inc. reported an EPS of -HK$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.373%.
Which hedge fund is a major shareholder of Yidu Tech, Inc.?
Currently, no hedge funds are holding shares in HK:2158
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yidu Tech, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.55%
12-Months-Change
Fundamentals
Return on Equity
-2.28%
Trailing 12-Months
Asset Growth
-1.48%
Trailing 12-Months
Company Description
Yidu Tech, Inc.
Yidu Tech, Inc. is a leading healthcare technology company based in China, specializing in providing data-driven solutions for the healthcare sector. The company integrates artificial intelligence and big data analytics to enhance the efficiency and quality of healthcare delivery. Yidu Tech's core products include medical data platforms, AI-driven diagnostic tools, and healthcare management systems, which cater to hospitals, healthcare providers, and pharmaceutical companies.
2158 Stock 12 Month Forecast
Average Price Target
HK$11.00
▲(97.13% Upside)
Technical Analysis
China Isotope & Radiation Corp.
―
Mediwelcome Healthcare Management & Technology Inc.
―
Beijing Airdoc Technology Co. Ltd. Class H
―
CStone Pharmaceuticals
―
China Shineway Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---